Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)

NCT06698198 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Immunization

Interventions

BIOLOGICAL: Pneumococcal Conjugate Vaccine
BIOLOGICAL: Prevnar 13®

Sponsor

Sanofi Pasteur, a Sanofi Company